Literature DB >> 24455532

Tamoxifen-induced endometrial carcinoma after a lag of 14 years.

Anil Kumar Dhull1, Vivek Kaushal1, Sunita Singh2, Rajeev Sen2.   

Abstract

Entities:  

Year:  2013        PMID： 24455532      PMCID： PMC3876637          DOI： 10.4103/2278-330X.105867

Source DB:  PubMed          Journal:  South Asian J Cancer        ISSN： 2278-330X


× No keyword cloud information.
  3 in total

Review 1.  Tamoxifen and endometrial neoplasia.

Authors:  R R Barakat
Journal:  Clin Obstet Gynecol       Date:  1996-09       Impact factor: 2.190

Review 2.  Surveillance for endometrial cancer in women receiving tamoxifen.

Authors:  E J Suh-Burgmann; A Goodman
Journal:  Ann Intern Med       Date:  1999-07-20       Impact factor: 25.391

3.  Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and reduction in IGF binding proteins.

Authors:  D Kleinman; M Karas; M Danilenko; A Arbell; C T Roberts; D LeRoith; J Levy; Y Sharoni
Journal:  Endocrinology       Date:  1996-03       Impact factor: 4.736
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.